SCHEMBL31489488

SCHEMBL31489488

FCCC(c1ccc(F)cc1)n1cc(-c2ccnc(Cl)n2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.39
DYRK1B Q9Y463 3/20 0.37
MAPT P10636 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
CYP19A1 P11511 2/20 0.34
CYP17A1 P05093 2/20 0.33
MAPK3 P27361 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
RPS6KB1 P23443 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
ATM Q13315 1/20 0.31
JAK2 O60674 2/20 0.31
GRM5 P41594 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489513 0.87 MKNK1 (0.40) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL31489233 0.85 MKNK1 (0.39) MKNK1DYRK1BMAPTL3MBTL1MAPK3
SCHEMBL31489373 0.79 MKNK1 (0.38) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL31489305 0.79 MKNK1 (0.38) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL31489570 0.78 MKNK1 (0.40) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL31489637 0.77 MKNK1 (0.39) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL31489134 0.77 MEN1 (0.34) MKNK1DYRK1BMAPTL3MBTL1MEN1
SCHEMBL19555915 0.76 MKNK1 (0.37) MKNK1DYRK1BJAK2GABRA1GABRG2
SCHEMBL31489266 0.69 CYP17A1 (0.40) MKNK1CYP19A1CYP17A1JAK2
SCHEMBL446173 0.68 MEN1 (0.58) MAPTL3MBTL1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed